Fig. 16From: De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learninga Experimental binding pose of peptidomimetic inhibitor GRL-0240-20 (PDB: 6XR3) and b docked pose of LaBECFar-5 on SARS-COV-2 Mpro. (PDB: 6W79). The amido acid residues are shown as beige sticks and the ligands as orange sticksBack to article page